Noticias

Zacks3h agoneutral

CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy

CVRX stock gains after Humana adds Medicare Advantage coverage for Barostim therapy, boosting reimbursement momentum and patient access.

Zacks3d agoneutral

Here's Why You Should Add Pediatrix Medical to Your Portfolio Now

MD gains from stronger cash collections, payer mix and acquisitions, while telehealth expansion and buybacks support growth.

Zacks4d agoneutral

RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone Assay

Revvity gains FDA clearance for IDS' Total Testosterone assay, expanding its automated endocrine testing platform for reproductive diagnostics.

WST

Zacks4d agoneutral

Reasons to Hold HealthEquity Stock in Your Portfolio for Now

HQY rides on strong HSA growth, AI-driven efficiency gains and solid Q4 results, though data security threats remain a key risk.

WST

Cybersecurity Dive4d agoneutral

West Pharmaceutical starts restoring operations after ransomware attack

The company confirmed data was stolen and encrypted by the attackers.

PANW WST

Simply Wall St.5d agoneutral

Does West Pharmaceutical’s Rejected Independent Chair Proposal Reflect a Stable Governance Edge for WST?

On May 4, 2026, West Pharmaceutical Services held its annual general meeting, where shareholders voted against a proposal to require an independent board chair policy. This governance outcome comes as the company has recently delivered earnings above consensus expectations, reinforcing the influence of financial performance on investor voting behavior. Against this backdrop of robust recent earnings surprises, we'll examine how the board chair vote outcome may reshape West Pharmaceutical's...

WST